"Pyrazinamide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pyrazine that is used therapeutically as an antitubercular agent.
Below are MeSH descriptors whose meaning is more general than "Pyrazinamide".
Below are MeSH descriptors whose meaning is more specific than "Pyrazinamide".
This graph shows the total number of publications written about "Pyrazinamide" by people in Harvard Catalyst Profiles by year, and whether "Pyrazinamide" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 0 | 2 | 2 |
2002 | 1 | 0 | 1 |
2004 | 2 | 3 | 5 |
2005 | 0 | 2 | 2 |
2006 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2010 | 0 | 2 | 2 |
2011 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 1 | 1 | 2 |
2016 | 1 | 1 | 2 |
2017 | 3 | 0 | 3 |
2018 | 1 | 1 | 2 |
2019 | 1 | 1 | 2 |
2020 | 1 | 2 | 3 |
2021 | 1 | 0 | 1 |
2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Pyrazinamide" by people in Profiles.
-
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s. Antimicrob Agents Chemother. 2023 11 15; 67(11):e0073723.
-
An explainable machine learning platform for pyrazinamide resistance prediction and genetic feature identification of Mycobacterium tuberculosis. J Am Med Inform Assoc. 2021 03 01; 28(3):533-540.
-
Reply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis. Am J Respir Crit Care Med. 2020 06 15; 201(12):1579-1580.
-
Multiple tuberculomas in an immunocompetent patient and their diagnostic challenge in a high prevalence country: Case report and literature review. Indian J Tuberc. 2020 Jul; 67(3):286-294.
-
A Complete Triad: Horner's Syndrome in Tuberculous Meningitis. Am J Med Sci. 2020 08; 360(2):204-205.
-
Pyrazinamide triggers degradation of its target aspartate decarboxylase. Nat Commun. 2020 04 03; 11(1):1661.
-
Are pretomanid-containing regimens for tuberculosis a victory or a victory narrative? Lancet Respir Med. 2019 12; 7(12):999-1000.
-
Potentially High Number of Ineffective Drugs with the Standard Shorter Course Regimen for Multidrug-Resistant Tuberculosis Treatment in Haiti. Am J Trop Med Hyg. 2019 02; 100(2):392-398.
-
Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis. PLoS One. 2018; 13(9):e0204495.
-
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. N Engl J Med. 2018 10 11; 379(15):1403-1415.